发明名称 Oral pharmaceutical dosage forms
摘要 Controlled release oral dosage forms suitable for administration of methylphenidate are provided. Abuse-resistant controlled release oral dosage forms suitable for administration of methylphenidate are also provided. Methods of treating ADD and ADHD using the oral dosage forms are also provided.
申请公布号 US9616055(B2) 申请公布日期 2017.04.11
申请号 US201514791073 申请日期 2015.07.02
申请人 Durect Corporation 发明人 Scicinski Jan J.;van Osdol William W.;Su Huey-Ching;Arenberg Michael H.;Shah Jaymin
分类号 A61K31/4458;A61K9/00;A61K9/16;A61K9/48;A61K9/50 主分类号 A61K31/4458
代理机构 Bozicevic, Field & Francis LLP 代理人 Rubin Michael B.;Bozicevic, Field & Francis LLP
主权项 1. An oral controlled release dosage form comprising a formulation comprising: methylphenidate at about 5 to about 30 wt % relative to the total weight of the formulation; sucrose acetate isobutyrate (SAIB) at about 30 to about 45 wt % relative to the total weight of the formulation; a rheology modifier at about 2 to about 15 wt % relative to the total weight of the formulation; a network former at about 2 to about 10 wt % relative to the total weight of the formulation; a solvent at about 15 to about 40 wt % relative to the total weight of the formulation; a viscosity enhancing agent at about 0.1 to about 2 wt % relative to the total weight of the formulation; and a saturated polyglycolized glyceride at about 0.01 to about 5 wt % relative to the total weight of the formulation.
地址 Cupertino CA US